Sign up for the QMED & MD+DI Daily newsletter.
Elucid Raises $80M in Series C Funding
Funding was led by Elevage Medical Technologies. Elucid has now hit a total of $121 million in funding since the company’s inception.
November 10, 2023
1 Min Read
champc / iStock via Getty Images
Elucid, a medtech company providing cardiovascular-focused AI-powered imaging analysis software, recently announced it has raised $80 million in Series C funding. The funding was led by Elevage Medical Technologies, with participation from both industry strategics and existing investors. The company’s funding now totals $121 million since inception.
“Elevage believes leading this investment in Elucid is pivotal to support the development and commercialization of its groundbreaking diagnostic tools,” said Dr. Evan Melrose, CEO of Elevage, in a press release. “We see an important market need for AI-powered cardiovascular software and are excited to partner with Elucid to help improve the diagnosis and management of heart disease and benefit patients worldwide.”
Elucid’s software addresses the need for objective, non-invasive diagnostic methods that more accurately quantify and characterize plaque, they said. It is FDA cleared and able to accurately characterize arterial plaque, which simulates what pathologists would see under a microscope, establishing a histologic ground truth.
Currently, the company is pursuing an additional indication for noninvasive measurement of fractional flow reserve, “uniquely derived from its PlaqueIQ technology, to measure coronary blockages and the extent of ischemia,” according to the release.
Along with the news of the funding, Elucid also announced new additions to its board of directors, namely, Dr. Melrose and Dr. Kelly Huang, Elevage senior advisor.
About the Author(s)
Managing Editor, MD+DI
Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].
You May Also Like
Sustainable Manufacturing Expo Hits North AmericaFeb 22, 2024|4 Min Read
Medtronic Doubles Down on Sustainability EffortsFeb 22, 2024|1 Min Read
Top Medical Device M&AFeb 21, 2024|1 Min Read
FDA Urges Independent Verification of Third-Party Testing DataFeb 21, 2024|2 Min Read